XML 26 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:      
Net income $ 779,437 $ 474,505 $ 621,674
Adjustment to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 159,609 156,758 154,850
Amortization of right-of-use assets 34,232 34,760 26,523
Stock-based compensation costs (note 11) 65,257 63,927 57,559
Loss attributable to equity method investments (note 6) 8,486 11,205 25,058
(Gain) loss on equity investments (note 6) 12,202 (14,515) 14,519
Restructuring expenses (note 17) 0 8,673 0
Changes in fair value of business combination contingent consideration 0 0 (7)
Changes in operating assets and liabilities:      
Accounts receivable 19,346 (129,195) 54,383
Inventories (311,681) (21,954) (69,881)
Prepaid expenses, net deferred income taxes and other current assets (168,109) (58,154) (58,999)
Accounts payable, accrued expenses and other (247,632) 210,708 (23,424)
Net cash provided by operating activities 351,147 736,718 802,255
Cash flows from investing activities:      
Purchases of property, plant and equipment (134,835) (102,712) (95,330)
Patent registration costs (21,201) (14,114) (10,608)
Business acquisitions, net of cash acquired (42,784) (39,067) (27,910)
Purchases of investments (note 6) (20,724) (21,788) (31,616)
Proceeds from sale of investment (note 6) 6,802 0 0
(Payments) / proceeds on maturity of foreign currency contracts (17,176) 19,219 (14,397)
Net cash used in investing activities (229,918) (158,462) (179,861)
Cash flows from financing activities:      
Proceeds from issuance of common stock, net 47,384 37,790 48,182
Taxes paid related to net share settlement of equity awards (52,406) (50,209) (46,061)
Payments of business combination contingent consideration 0 (3,500) (302)
Proceeds from borrowings, net of borrowing costs 288,000 90,000 1,190,000
Repayment of borrowings (166,000) (612,000) (1,284,012)
Dividends paid (245,341) (226,713) (225,093)
Net cash used in financing activities (128,363) (764,632) (317,286)
Effect of exchange rate changes on cash (14,434) 18,498 10,920
Net increase (decrease) in cash and cash equivalents (21,568) (167,878) 316,028
Cash and cash equivalents at beginning of period 295,278 463,156 147,128
Cash and cash equivalents at end of period 273,710 295,278 463,156
Supplemental disclosure of cash flow information:      
Income taxes paid, net of refunds 478,120 221,359 180,359
Interest paid 22,312 23,989 40,377
Fair value of assets acquired, excluding cash 15,648 16,671 14,919
Liabilities assumed (4,672) (1,543) (4,292)
Goodwill on acquisition 38,953 24,671 20,375
Previously held equity interest (4,078) 0 0
Deferred payments (3,067) 3,768 408
Fair value of contingent consideration 0 (3,500)
Cash paid for acquisitions $ 42,784 $ 43,567 $ 27,910